ES2089974B1 - Utilizacion de los derivados de 1-(4-)4-aril (o heteroaril)-1-piperazinil)-butil)-1-h-azol para la preparacion de medicamentos destinados al tratamiento de los trastornos de la secrecion gastrica. - Google Patents
Utilizacion de los derivados de 1-(4-)4-aril (o heteroaril)-1-piperazinil)-butil)-1-h-azol para la preparacion de medicamentos destinados al tratamiento de los trastornos de la secrecion gastrica.Info
- Publication number
- ES2089974B1 ES2089974B1 ES09402417A ES9402417A ES2089974B1 ES 2089974 B1 ES2089974 B1 ES 2089974B1 ES 09402417 A ES09402417 A ES 09402417A ES 9402417 A ES9402417 A ES 9402417A ES 2089974 B1 ES2089974 B1 ES 2089974B1
- Authority
- ES
- Spain
- Prior art keywords
- piperazinyl
- butyl
- treatment
- derivatives
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
Abstract
UTILIZACION DE LOS DERIVADOS DE 1-(4-[4-ARIL(O HETEROARIL)-1-PIPERAZINIL]-BUTIL)-1-HAZOL, PARA LA PREPARACION DE MEDICAMENTOS DESTINADOS AL TRATAMIENTO DE LOS TRANSTORNOS DE LA SECRECION GASTRICA. LA PRESENTE INVENCION CONCIERNE LA UTILIZACION DE LOS DERIVADOS DE 1-(4-[4-ARIL(O HETEROARIL)-1-PIPERAZINIL]-BUTIL)-1-HAZOL, ASI COMO DE SUS SALES FISIOLOGICAMENTE ACEPTABLES, PARA LA FABRICACION DE MEDICAMENTOS DESTINADOS AL TRATAMIENTO DE LOS TRASTORNOS ASOCIADOS A LA SECRECION GASTRICA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9314102A FR2712808B1 (fr) | 1993-11-25 | 1993-11-25 | Utilisation des dérivés de 1-{4-[4-aryl(ou hétéroaryl)-1-pipérazinyl]-butyl}-1-H-azole pour la préparation de médicaments destinés au traitement des troubles de la sécrétion gastrique . |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2089974A1 ES2089974A1 (es) | 1996-10-01 |
ES2089974B1 true ES2089974B1 (es) | 1997-03-16 |
Family
ID=9453220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES09402417A Expired - Lifetime ES2089974B1 (es) | 1993-11-25 | 1994-11-24 | Utilizacion de los derivados de 1-(4-)4-aril (o heteroaril)-1-piperazinil)-butil)-1-h-azol para la preparacion de medicamentos destinados al tratamiento de los trastornos de la secrecion gastrica. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5532234A (es) |
EP (1) | EP0655248B1 (es) |
JP (1) | JPH07242626A (es) |
AT (1) | ATE184485T1 (es) |
AU (1) | AU674458B2 (es) |
CA (1) | CA2136661A1 (es) |
DE (1) | DE69420679D1 (es) |
ES (1) | ES2089974B1 (es) |
FR (1) | FR2712808B1 (es) |
ZA (1) | ZA949332B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5646281A (en) | 1990-12-28 | 1997-07-08 | Neurogen Corporation | Certain 4-piperidino- and piperazinomethyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands |
US5681956A (en) * | 1990-12-28 | 1997-10-28 | Neurogen Corporation | 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands |
AU6318996A (en) * | 1995-07-07 | 1997-02-10 | Taisho Pharmaceutical Co., Ltd. | 4-alkylthiazoline derivatives |
FR2763950B1 (fr) | 1997-06-02 | 2002-09-20 | Esteve Labor Dr | 2- {4- [4-(4,5-dichloro-2-methylimidazol-1-yl)butyl] -1- piperazinyl }-5-fluoropyrimidine, sa preparation et son utilisation therapeutique |
US6166205A (en) * | 1998-09-02 | 2000-12-26 | Neurogen Corporation | 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands |
WO2000051547A2 (en) * | 1999-03-03 | 2000-09-08 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
US7589202B2 (en) | 2000-08-14 | 2009-09-15 | Ortho Mcneil Pharmaceutical, Inc. | Substituted pyrazoles |
DE60118004T2 (de) | 2000-08-14 | 2006-11-16 | Ortho-Mcneil Pharmaceutical, Inc. | Substituierte pyrazole |
US7332494B2 (en) | 2000-08-14 | 2008-02-19 | Janssen Pharmaceutica, N.V. | Method for treating allergies using substituted pyrazoles |
JP4911864B2 (ja) | 2000-08-14 | 2012-04-04 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 置換ピラゾール |
RU2003106192A (ru) | 2000-09-06 | 2004-07-27 | Орто-Макнейл Фармасьютикал, Инк. (Us) | Способ лечения аллергий |
GB2435827A (en) * | 2006-03-09 | 2007-09-12 | Del Dr Esteve S A Spain Lab | Use of substituted piperazine compounds for the treatment of food related disorders |
EP2924032B1 (en) * | 2012-11-26 | 2019-03-06 | Shenyang Haiwang Biotechnology Co., Ltd | Benzo five-membered nitrogen heterocyclic piperidine or piperazine derivatives and preparation methods and pharmaceutical compositions thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2672052B1 (fr) * | 1991-01-28 | 1995-05-24 | Esteve Labor Dr | Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments. |
US5096908A (en) * | 1990-05-04 | 1992-03-17 | Eli Lilly And Company | Method of inhibiting gastric acid secretion |
-
1993
- 1993-11-25 FR FR9314102A patent/FR2712808B1/fr not_active Expired - Fee Related
-
1994
- 1994-11-23 AT AT94402673T patent/ATE184485T1/de active
- 1994-11-23 EP EP94402673A patent/EP0655248B1/fr not_active Expired - Lifetime
- 1994-11-23 DE DE69420679T patent/DE69420679D1/de not_active Expired - Lifetime
- 1994-11-23 US US08/344,377 patent/US5532234A/en not_active Expired - Fee Related
- 1994-11-24 ES ES09402417A patent/ES2089974B1/es not_active Expired - Lifetime
- 1994-11-24 ZA ZA949332A patent/ZA949332B/xx unknown
- 1994-11-24 AU AU79007/94A patent/AU674458B2/en not_active Ceased
- 1994-11-25 JP JP6290838A patent/JPH07242626A/ja active Pending
- 1994-11-25 CA CA002136661A patent/CA2136661A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ZA949332B (en) | 1995-11-14 |
ES2089974A1 (es) | 1996-10-01 |
US5532234A (en) | 1996-07-02 |
FR2712808B1 (fr) | 1996-02-16 |
ATE184485T1 (de) | 1999-10-15 |
AU7900794A (en) | 1995-06-01 |
AU674458B2 (en) | 1996-12-19 |
JPH07242626A (ja) | 1995-09-19 |
FR2712808A1 (fr) | 1995-06-02 |
EP0655248A1 (fr) | 1995-05-31 |
CA2136661A1 (fr) | 1995-05-26 |
DE69420679D1 (de) | 1999-10-21 |
EP0655248B1 (fr) | 1999-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0008331A (pt) | Derivados de 16-halogeno-epotilon, processos para a sua preparação e seu emprego farmacêutico | |
SE8804629D0 (sv) | New therapeutically active compounds | |
ES2089974B1 (es) | Utilizacion de los derivados de 1-(4-)4-aril (o heteroaril)-1-piperazinil)-butil)-1-h-azol para la preparacion de medicamentos destinados al tratamiento de los trastornos de la secrecion gastrica. | |
FI88037B (fi) | Foerfarande foer framstaellning av farmaceutiskt vaerdefullt kristallint (4r,5s,6s,8r,2's,4's)-3-/4-(2-dimetylaminokarbonyl)-pyrrolidinyltio/-4-metyl-6-(1-hydroxietyl)-1-azabicyklo-/3,2,0/-hept-2-en-7-on-2-karboxylsyratrihydrat | |
BR0109703A (pt) | Derivados de piperazina | |
DK256890A (da) | Benzo-piperidin-, -piperidyliden- og piperazinforbindelser, kompositioner indeholdende forbindelserne og fremgangsmaader til forbindelsernes fremstilling og anvendelse | |
AR018197A1 (es) | Compuestos de piperidina, un procedimiento para su preparacion, una composicion y uso del mismo para la preparacion de un medicamento | |
AR012504A1 (es) | Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion. | |
ATE108437T1 (de) | Substituierte diaminophthalimide und analoga. | |
MX9300779A (es) | 3-(1h-tetrazol-5-y1)-4h-pyrido[1,2-a]pirimidina-4-onas composiciones farmaceuticas que las contienen y su preparacion de las mismas | |
BR9611871B1 (pt) | diaminopirimidinas, compostos intermediários para a sìntese das mesmas, bem como medicamento que as contém. | |
AR004378A1 (es) | Utilizacion de los derivados de 1-{4-(4-aril(o heteroaril)-1-piperazinil)- butil}-1h-azol para la preparacion de un medicamento destinado al tratamientode los trastornos obsesivo-compulsivos, la apnea del sueno, las disfunciones sexuales, la emesis y el mareo en los mamiferos, incluido el hombre. | |
NO975028D0 (no) | Piperazinoderivater som neurokininantagonister | |
DK0527081T3 (da) | Hidtil ukendte substituerede 3-piperazinylalkyl-2,3-dihydro-1,3-4H-benzoxazin-4-oner, deres fremstilling og terapeutiske anvendelse | |
NO178336C (no) | Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse og mellomprodukter | |
WO2003051838A3 (en) | Protein kinase inhibitors | |
NO940274L (no) | 2-(4-(4-azolbutyl)-1-piperazinyl)-5-hydroksy-pyrimidinderivater, deres fremstilling og anvendelse som legemidler | |
EP1123923A4 (en) | DIHYDROPYRIDINE DERIVATIVES AND DRUG BLOCK CONTAINING THESE | |
ATE139523T1 (de) | Neue verbindungen und deren medizinale verwendung | |
DK557189D0 (da) | 1,2,3,4-tetrahydro-1,9-acridindiaminer, deres fremstilling og anvendelse som laegemidler | |
PE20030236A1 (es) | Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados | |
GR880300076T1 (en) | 2-benzimidazolylalkylthio (or sulfinyl or sulfonyl) derivatives, their preparation and their use as medicaments | |
DK114286A (da) | Pyridylmethylnaphthylderivater eller fysiologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler | |
ES2191022T3 (es) | Utilizacion de derivados de la tetrahidropiridina para la preparacion de medicamentos cardioprotectores. | |
DK47988D0 (da) | Substituerede 3-phenyl-7h-thiazolooe3,2-baaoe1,2,4aatriazin-7-oner, deres fremstilling og anvendelse som laegemiddel, samt ved fremstillingen anvendelige mellemprodukter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 19961001 Kind code of ref document: A1 Effective date: 19961001 |
|
EC2A | Search report published |
Date of ref document: 19961001 Kind code of ref document: A1 Effective date: 19961001 |